Selank vs Semax
Selank and Semax are both Russian-developed nootropic peptides approved for clinical use in Russia, making them among the few peptides with actual regulatory approval (outside the US). They are often compared because both target cognitive function, but through very different neurotransmitter pathways.
Side-by-Side Comparison
| Category | Selank | Semax |
|---|---|---|
| Mechanism of action | Synthetic analog of tuftsin (immunomodulatory peptide). Modulates GABA-A receptors, enhances enkephalin stability, and has anxiolytic effects. Regulates IL-6 and affects serotonin metabolism. | Synthetic analog of ACTH(4-10). Increases BDNF expression (~1.4x protein, up to 3x mRNA in animal studies), modulates dopaminergic and serotonergic systems, and has neuroprotective effects. |
| Primary research area | Anxiety reduction, stress resilience, immunomodulation. Approved in Russia as an anxiolytic. Also studied for cognitive enhancement under stress. | Cognitive enhancement, neuroprotection, stroke recovery. Approved in Russia for stroke recovery and cognitive disorders. Also studied for ADHD and optic nerve conditions. |
| Evidence level | Approved medication in Russia. Published human studies on anxiety and cognitive function. Limited Western clinical trials. Not FDA-approved. | Approved medication in Russia for stroke. Published human studies on cognitive performance and neuroprotection. Some Western research interest. Not FDA-approved. |
| Administration route | Intranasal spray (approved route in Russia) or subcutaneous injection. | Intranasal spray (approved route in Russia) or subcutaneous injection. |
| Typical research dosing | Intranasal: 250-500 mcg per day (divided into 2-3 administrations). Cycles of 2-4 weeks. | Intranasal: 200-600 mcg per day (divided into 2-3 administrations). Cycles of 2-4 weeks. |
| Key studies/evidence | Zozulia et al. — anxiolytic effects in human subjects. Ershov et al. — immunomodulatory effects. Russian Ministry of Health approval as anxiolytic nasal spray. | Ashmarin et al. — BDNF upregulation studies. Gusev et al. — stroke recovery in human trials. Russian Ministry of Health approval for stroke and cognitive disorders. |
Can They Be Stacked?
A widely-used combination known as the "flow state" stack. Semax provides drive and focus through BDNF upregulation while Selank calms anxiety through GABA modulation. The complementary mechanisms (stimulation + anxiolysis) are well-supported by their distinct pharmacology. Both approved for concurrent use in Russian clinical practice.
Verdict
Selank is primarily anxiolytic (calming, stress-reducing) while Semax is primarily stimulating (focus, drive, BDNF). The choice depends on whether anxiety or cognitive performance is the primary concern. Selank is better studied for generalized anxiety and stress, while Semax has stronger evidence for neuroprotection and cognitive enhancement. Both have the advantage of approved clinical use in Russia, though this doesn't meet FDA standards.
Related Comparisons
Dihexa and Semax are both studied for cognitive enhancement, but they differ dramatically in evidence level and risk profile. Semax is an approved medication in Russia with decades of clinical data, while Dihexa is a potent research compound with limited safety data beyond animal studies.
Semax vs Cerebrolysin: Nootropic Peptide ComparisonSemax and Cerebrolysin are both neuropeptides with decades of clinical use in Russia and Europe, yet they differ fundamentally in origin, administration, and mechanism. Semax is a synthetic heptapeptide analog of ACTH(4-10) originally developed at the Institute of Molecular Genetics in Moscow. Cerebrolysin is a porcine brain-derived peptide preparation containing a complex mixture of neurotrophic factors and free amino acids, manufactured by EVER Neuro Pharma in Austria. Both target brain-derived neurotrophic factor (BDNF) pathways and have been studied for cognitive enhancement, neuroprotection, and neurological recovery -- but they occupy very different niches in terms of convenience, evidence base, and intended use cases.
Disclaimer: This content is for educational purposes only and does not constitute medical advice. Peptides are biologically active compounds that carry risks. Consult a healthcare provider before using any peptides. Many peptides discussed here have limited human clinical data — always verify current research status before making decisions.